Newsletter | May 13, 2026

05.13.26 -- Kodak Flips The Script To Pharmaceutical Manufacturing In Rochester

SPONSOR

Formulation & Delivery Of Spray Dried Biologics For Nasal Dosage Forms

Learn more about the benefits and applications of spray drying in the development and manufacture of biologics for nasal dosage forms, alongside excipient selection, development timelines, testing methods, devices, and GMP manufacture. Read the white paper.

INDUSTRY INSIGHTS

High Shear Wet Granulation Scale-Up Using Basic Principles

Leverage impeller tip speed and equivalent revolutions as a practical scale-up strategy to ensure consistent, high-quality wet granulation performance across equipment and batch sizes.

The 5 Key Risks Of Failing To Select The Right CDMO Partner

For complex projects involving oral solid dosage (OSD) and sterile drug products, selecting the ideal CDMO can play a pivotal role in determining the success of a drug candidate.

Compound Library Consortium

Explore how a novel approach to enhancing drug discovery efforts can significantly improve the chances of identifying promising drug candidates, ultimately accelerating the path from discovery to development.

FEATURED EDITORIAL

Kodak Flips The Script To Biopharma Manufacturing In Rochester

Well, that didn’t work out as planned, writes Chief Editor Louis Garguilo, referring to Kodak's strategy in 2018 to revitalize the Eastman Business Park in Rochester, NY. The incoming chairman and now CEO, Jim Continenza, didn’t like that movie, and flipped the script. Instead, Kodak has, so to speak, returned to itself – back to a domestic specialty materials and chemicals supplier, intent on serving biopharma in that capacity.

Building Quality Into Radiopharmaceuticals: A Look At EMA's Recent Guideline

The EMA's December 2025 draft guideline on expectations for the quality documentation of radiopharmaceuticals replaces the earlier 2007 guideline and reflects significant developments.

INDUSTRY INSIGHTS CONTINUED

Cold Chain Logistics And Packaging Considerations For Probiotics

Choosing the right packaging partner for your probiotic may be the most crucial step to ensuring your product is safe and potent when it reaches the consumer.

De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept

Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.

Identify Lead Solid Form Early To Reduce Timelines And Downstream Costs

Devoting early-phase resources for solid form understanding and screening during a drug’s development lifecycle is critical, as doing so can help save time and resources on the path to market.

SOLUTIONS

Driving Excellence In Small‑Molecule Drug Substance Production

Regulatory Services Offering

Bend, Oregon, US: Advancing Compounds Through Early Development

From Risk To Readiness: Strategic Regulatory Support

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: